Secukinumab Therapy in Psoriasis Management

Background : In recent years, use of biological therapy in psoriasis has increased as a result of advances in understanding the pathophysiology of psoriasis disease. Biological agents currently approved for the treatment of moderate to severe plaque psoriasis including inhibitor TNF-α (adalimumab, e...

Full description

Saved in:
Bibliographic Details
Main Authors: Ira Yunita (Author), Sylvia Anggraeni (Author)
Format: Book
Published: Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available